Pathogenesis of Noonan syndrome is modulated by NOC2L, a novel interactor of LZTR1 leading to impaired p53 signalling

Journal:
Journal of Clinical Endocrinology & Metabolism
Published:
Affiliations:
4
Authors:
8
Institutions Authors Share
William Harvey Research Institute (WHRI), QMUL, United Kingdom (UK)
5.000000
0.63
University of São Paulo (USP), Brazil
1.000000
0.13
University of Birmingham, United Kingdom (UK)
1.000000
0.13
University of Reading, United Kingdom (UK)
1.000000
0.13